Dashboard
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- Low ability to service debt as the company has a high Debt to EBITDA ratio of -1.00 times
- The company has reported losses. Due to this company has reported negative ROCE
Flat results in Sep 26
Risky - Negative EBITDA
Below par performance in long term as well as near term
Stock DNA
Commodity Chemicals
INR 33 Cr (Micro Cap)
NA (Loss Making)
23
0.00%
1.00
-23.50%
1.47
Total Returns (Price + Dividend) 
TCM for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

TCM Ltd Downgraded to Strong Sell Amid Weak Financials and Deteriorating Technicals
TCM Ltd, a micro-cap player in the commodity chemicals sector, has seen its investment rating downgraded from Sell to Strong Sell as of 9 November 2026. This revision reflects deteriorating technical indicators, stagnant financial performance, and poor valuation metrics, signalling heightened risk for investors amid a challenging market environment.
Read More
TCM Ltd is Rated Strong Sell by MarketsMOJO
TCM Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 30 September 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 October 2026, providing investors with the latest insights into the company’s performance and outlook.
Read More
TCM Ltd Downgraded to Strong Sell Amid Technical and Financial Weaknesses
TCM Ltd, a micro-cap player in the commodity chemicals sector, has been downgraded from a Sell to a Strong Sell rating as of 30 September 2026. This revision reflects deteriorating technical indicators, flat financial performance, and weak fundamental metrics, signalling heightened risk for investors despite the stock’s recent market-beating returns.
Read More Announcements 
Announcement under Regulation 30 (LODR)-Updates on Joint Venture
19-Nov-2026 | Source : BSEFurther to our Corporate Announcements dated 18th September 2026 and 17th November 2026 purusuant to Regulation 30 of SEBI Listing Regulations we wish to inform you that TCM Limited has executed a Joint Development Agreement (JDA) on Thursday 19th November 2026 at Kochi with Asset TCM Estates Private Limited a Joint Venture Company in which Asset Homes Private Limited and Mr. Suhas Nandan are the other shareholders for the joint development of 2.5 acres of land situated at Kalamassery Ernakulam Kerala for the development and construction of a premium residential villa project.
Announcement under Regulation 30 (LODR)-Updates on Joint Venture
17-Nov-2026 | Source : BSEFurther to our Corporate Announcement dated 18th September 2026 as referred in the attachment in terms of SEBI Listing Regulations we wish to inform you that our Company has executed the Shareholders Agreement with Asset Homes Private Limited and Mr. Suhas Nandan today 17th November 2026 at Kochi for the purpose of the Joint Venture for the land development of 2.5 Acres of land at Kalamassery with the Joint Venture Company as - Asset TCM Estates Private Limited incorporated with the purpose of construction of premium residential villa project at Kalamassery Ernakulam.
Announcement under Regulation 30 (LODR)-Newspaper Publication
07-Nov-2026 | Source : BSEPursuant to Regulation 30 and 47 of SEBI(LODR) Regulations 2015 we are forwarding herewith copies of Newspaper clippings regarding Unaudited Consolidated and Standalone financial results for the quarter ended 30th September 2026 published on Saturday 07th November 2026 in Financial Express in English language and Deepika in vernacular daily.
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
TCM Ltd has announced 6:5 rights issue, ex-date: 26 Apr 22
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 0 FIIs
Joseph Varghese (49.48%)
Lici Asm Non Par (7.14%)
39.14%
Quarterly Results Snapshot (Consolidated) - Sep'26 - YoY
YoY Growth in quarter ended Sep 2026 is 2.03% vs -14.20% in Sep 2025
YoY Growth in quarter ended Sep 2026 is -7.69% vs -36.84% in Sep 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is -25.04% vs -1.30% in Sep 2024
Growth in half year ended Sep 2025 is -94.84% vs 33.19% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is -19.28% vs -22.34% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -72.61% vs -51.57% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is -24.11% vs -19.30% in Mar 2025
YoY Growth in year ended Mar 2026 is -460.87% vs 182.56% in Mar 2025